# XOLAIR

NDC: 50242-040
Generic name: omalizumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20030620

FDA application: BLA103976

## Active ingredients

- OMALIZUMAB: 150 mg/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d